Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Thrombasthenia D013915 4 associated lipids
Menorrhagia D008595 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Diseases in Twins D004200 4 associated lipids
Hyperaldosteronism D006929 4 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Purpura, Schoenlein-Henoch D011695 5 associated lipids
Sclerosis D012598 5 associated lipids
Pulmonary Embolism D011655 5 associated lipids
beta-Thalassemia D017086 5 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Ductus Arteriosus, Patent D004374 5 associated lipids
Placenta Diseases D010922 5 associated lipids
Intracranial Embolism and Thrombosis D002542 5 associated lipids
Facial Pain D005157 5 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Abortion, Habitual D000026 5 associated lipids
Mastocytosis D008415 5 associated lipids
Bartter Syndrome D001477 5 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hypercapnia D006935 5 associated lipids
Asthenia D001247 5 associated lipids
Respiration Disorders D012120 5 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Sneezing D012912 6 associated lipids
Bronchitis D001991 6 associated lipids
Intermittent Claudication D007383 6 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Thromboembolism D013923 6 associated lipids
Thrombophilia D019851 6 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Varicose Veins D014648 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Agranulocytosis D000380 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Femoral Fractures D005264 7 associated lipids
Bronchopneumonia D001996 7 associated lipids
Raynaud Disease D011928 7 associated lipids
Tachycardia D013610 7 associated lipids
Dyslipidemias D050171 7 associated lipids
Keratitis D007634 7 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Renal Artery Obstruction D012078 8 associated lipids
Enteritis D004751 8 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Karkabounas S et al. Anticarcinogenic and antiplatelet effects of carvacrol. 2006 Exp. Oncol. pmid:16837902
Anfossi G et al. Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets. 1991 Gen. Pharmacol. pmid:1684769
Röth E and Török B Effect of the ultrashort-acting beta-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state. 1991 Sep-Oct Basic Res. Cardiol. pmid:1685083
Shi T et al. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. 2006 Arthritis Rheum. pmid:16868978
Sciulli MG et al. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease. 2006 Clin. Pharmacol. Ther. pmid:16890573
Tuominen OM et al. Effects of bisphosphonates on prostaglandin E2 and thromboxane B2 production in human whole blood and monocytes stimulated by lipopolysaccharide and A23187. 2006 Jul-Aug Methods Find Exp Clin Pharmacol pmid:16894405
Stergioulas AT and Filippou DK Effects of physical conditioning on lipids and arachidonic acid metabolites in untrained boys: a longitudinal study. 2006 Appl Physiol Nutr Metab pmid:16900233
Nakache R et al. Pancreatic juice immunoreactive thromboxane B2 in pancreas allograft rejection. 1990 Transplant. Proc. pmid:1691546
Odor-Morales A et al. Urinary amylase, urinary insulin, or urinary thromboxane: which is the best predictor of pancreatic allograft rejection in the dog? 1990 Transplant. Proc. pmid:1691549
Kappa JR et al. Intraoperative management of patients with heparin-induced thrombocytopenia. 1990 Ann. Thorac. Surg. pmid:1692679
Swies J et al. Occlusion and reperfusion-induced arrhythmias in rats: involvement of platelets and effects of calcium antagonists. 1990 J. Cardiovasc. Pharmacol. pmid:1692943
Takehana Y et al. [Anti-allergic effects of (E)-3-[p-(1H-imidazol-1-lylmethyl) phenyl]-2-propenoic acid (OKY-046), a specific thromboxane (TX) A2 synthetase inhibitor: effects on type I allergic reactions]. 1990 Nippon Yakurigaku Zasshi pmid:1693906
Faraday N et al. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. 2006 Am. J. Cardiol. pmid:16950183
Matthias FR and Ditter H The effects of an infusion of prostacyclin on their endotoxin shock in rabbits. 1990 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:1695178
Renda G et al. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. 2006 Clin. Pharmacol. Ther. pmid:16952493
Nambu F et al. OKY-046 inhibits anaphylactic bronchoconstriction and reduces histamine level in bronchoalveolar lavage fluid in sensitized guinea pigs. 1990 Prostaglandins pmid:1695383
Abdullah NA and Assem ES Ischaemia and mediator release: interrelationship in antigen-challenged sensitized guinea-pig kidney. 1990 Agents Actions pmid:1695424
Berti F et al. Immune release of histamine and other lipid mediators from guinea-pig isolated kidney: antagonism by BN-52021. 1990 Agents Actions pmid:1696776
Zimlichman S et al. Serum amyloid A, an acute phase protein, inhibits platelet activation. 1990 J. Lab. Clin. Med. pmid:1697614
Ramamurthy S et al. Characterization of thromboxane A2 receptor signaling in developing rat oligodendrocytes: nuclear receptor localization and stimulation of myelin basic protein expression. 2006 J. Neurosci. Res. pmid:16998891
Nüsing R and Ullrich V Immunoquantitation of thromboxane synthase in human tissues. 1990 Eicosanoids pmid:1700725
Liu J et al. FcRgamma-chain signals in the absence of glycoprotein VI. 2007 J. Thromb. Haemost. pmid:17010148
Dołegowska B et al. Metabolism of eicosanoids and their action on renal function during ischaemia and reperfusion: the effect of alprostadil. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:17011760
Vidal C et al. Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis. 2007 J. Pharmacol. Exp. Ther. pmid:17015640
Ong TZ et al. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study. 2006 J. Clin. Gastroenterol. pmid:17016134
Logan JL et al. Dietary fish oil enhances renal hypertrophy in experimental diabetes. 1990 Diabetes Res. Clin. Pract. pmid:1702049
Conroy MC et al. Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949. 1990 J. Allergy Clin. Immunol. pmid:1702129
Morchón R et al. High levels of serum thromboxane B2 are generated during human pulmonary dirofilariosis. 2006 Clin. Vaccine Immunol. pmid:17028222
Cook-Johnson RJ et al. Endothelial cell COX-2 expression and activity in hypoxia. 2006 Biochim. Biophys. Acta pmid:17046322
Kimura Y et al. Prevention of myocardial reperfusion injury in experimental coronary revascularization following ischemic arrest by a novel antiinflammatory drug, ONO-3144. 1990 J. Cardiovasc. Pharmacol. pmid:1704995
Friton GM et al. Clinical and anti-inflammatory effects of treating endotoxin-challenged pigs with meloxicam. 2006 Vet. Rec. pmid:17056651
Ingenito EP et al. Effects of capsaicin on mechanical, cellular, and mediator responses to antigen in sensitized guinea pigs. 1991 Am. Rev. Respir. Dis. pmid:1705761
Ma K et al. [Study on comparative pharmacology of series of Muskone]. 2006 Zhongguo Zhong Yao Za Zhi pmid:17061560
Nagaoka H et al. Effects of aprotinin on prostaglandin metabolism and platelet function in open heart surgery. 1991 Jan-Feb J Cardiovasc Surg (Torino) pmid:1707053
Flipo RM [Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?]. 2006 Presse Med pmid:17078596
Hohlfeld T et al. Stimulation of prostacyclin synthesis by defibrotide: improved contractile recovery from myocardial "stunning". 1991 J. Cardiovasc. Pharmacol. pmid:1708043
Sturniolo R et al. Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat. 1991 J. Cardiovasc. Pharmacol. pmid:1709231
Miyamoto A et al. Ibuprofen or ozagrel increases NO release and l-nitro arginine induces TXA(2) release from cultured porcine basilar arterial endothelial cells. 2007 Vascul. Pharmacol. pmid:17113355
Maslov LN et al. [Participation of the prostacyclin-thromboxane system in the mechanisms of prevention of arrhythmia caused by occlusion of the coronary artery in adapted rats]. 1991 Biull Eksp Biol Med pmid:1711383
Tosaki A et al. Cicletanine and reperfusion injury: is there any correlation between arrhythmias, 6-keto-PGF1 alpha, thromboxane B2, and myocardial ion shifts (Na+, K+, Ca2+, and Mg2+) induced by ischemia/reperfusion in isolated rat heart. 1991 J. Cardiovasc. Pharmacol. pmid:1711620
Horn EH et al. A cross-sectional study of platelet cyclic AMP in healthy and hypertensive pregnant women. 1991 Clin. Sci. pmid:1711945
Gabler NK et al. Dietary onion intake as part of a typical high fat diet improves indices of cardiovascular health using the mixed sex pig model. 2006 Plant Foods Hum Nutr pmid:17123162
Valles J et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. 1991 Blood pmid:1712639
Venturinelli ML et al. Platelet activation in different clinical forms of the coronary artery disease (role of P-selectin and others platelet markers in stable and unstable angina). 2006 Arq. Bras. Cardiol. pmid:17128313
Jin UH et al. Inhibitory effect of Panax notoginseng on nitric oxide synthase, cyclo-oxygenase-2 and neutrophil functions. 2007 Phytother Res pmid:17128437
De Candia E et al. Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives. 2007 J. Thromb. Haemost. pmid:17137471
Morel DR et al. Leukotrienes, thromboxane A2, and prostaglandins during systemic anaphylaxis in sheep. 1991 Am. J. Physiol. pmid:1716064
Nosál R et al. Effect of chloroquine on isolated mast cells. 1991 Agents Actions pmid:1716835
Basili S et al. Insulin resistance as a determinant of platelet activation in obese women. 2006 J. Am. Coll. Cardiol. pmid:17174194
Yang YY et al. Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis. 2007 Clin. Sci. pmid:17176248
Hrushka NH et al. [Effect of thromboxane B2 on morphological features of apoptosis in cultured rat hepatocytes exposed to hepatotropic substances]. 2006 Fiziol Zh pmid:17176837
Gawaz MP and Ward RA Effects of hemodialysis on platelet-derived thrombospondin. 1991 Kidney Int. pmid:1719266
Saeed SA et al. Dual inhibition of cyclooxygenase and lipoxygenase by human haptoglobin: its polymorphism and relation to hemoglobin binding. 2007 Biochem. Biophys. Res. Commun. pmid:17198677
Komers R et al. Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats. 2007 Jan-Feb Clin. Exp. Pharmacol. Physiol. pmid:17201733
Lograno MD et al. Vascular eicosanoids and platelet-aortic wall interactions in spontaneously hypertensive rats. 1991 Eur. J. Pharmacol. pmid:1721028
Gasser JA and Betterridge DJ Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers. 1991 J. Cardiovasc. Pharmacol. pmid:1721976
Zhang JY et al. [Study on therapeutic effects of series of muskone on myocardial infarction canines]. 2006 Zhongguo Zhong Yao Za Zhi pmid:17225541
de Boer A et al. Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers. 1991 Thromb. Haemost. pmid:1722918
Fujiwara T et al. Exploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombogenicity. 2007 Pharmacogenomics J. pmid:17245331
Eligini S et al. Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1. 2007 Cardiovasc. Res. pmid:17250815
Lessa A et al. The effect of pentoxifylline on the pulmonary response to high tidal volume ventilation in rats. 2008 Pulm Pharmacol Ther pmid:17251044
Abdel-Haq B et al. Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects. 1991 J. Cardiovasc. Pharmacol. pmid:1725198
Millul V et al. Activation of guinea pig alveolar macrophages by endothelin-1. 1991 J. Cardiovasc. Pharmacol. pmid:1725342
Conroy DM et al. Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4. 1991 Br. J. Pharmacol. pmid:1725762
Dawood MY and Khan-Dawood FS Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea. 2007 Prostaglandins Other Lipid Mediat. pmid:17259081
Li XQ et al. [Experimental study on the treatment of hypertension with combined traditional Chinese and Western medicine]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:1725972
Wolfram RM et al. Salivary isoprostanes indicate increased oxidation injury in periodontitis with additional tobacco abuse. 2006 Biofactors pmid:17264390
Patel PM et al. Eicosanoid production in the caudate nucleus and dorsal hippocampus after forebrain ischemia: a microdialysis study. 1992 J. Cereb. Blood Flow Metab. pmid:1727145
Suzuki S et al. Evidence of acute inflammatory response in reexpansion pulmonary edema. 1992 Chest pmid:1729087
Nakamura K et al. Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. 2006 Cytokine pmid:17300951
Coppinger JA et al. Moderation of the platelet releasate response by aspirin. 2007 Blood pmid:17303692
Luceri C et al. p-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo. 2007 Br. J. Nutr. pmid:17313706
Park JB Caffedymine from cocoa has COX inhibitory activity suppressing the expression of a platelet activation marker, P-selectin. 2007 J. Agric. Food Chem. pmid:17319684
Guthikonda S et al. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. 2007 J. Thromb. Haemost. pmid:17319904
Rohatagi S et al. Predictive population pharmacokinetic/pharmacodynamic model for a novel COX-2 inhibitor. 2007 J Clin Pharmacol pmid:17322148
Maree AO et al. Drug insight: aspirin resistance-fact or fashion? 2007 Nat Clin Pract Cardiovasc Med pmid:17330121
Kurki T et al. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin. 1992 Am. J. Obstet. Gynecol. pmid:1733190
Ivandic BT et al. Determination of aspirin responsiveness by use of whole blood platelet aggregometry. 2007 Clin. Chem. pmid:17332149
Calzada C et al. In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase. 2007 J. Clin. Endocrinol. Metab. pmid:17341567
Fomsgaard JS et al. Comparison of thromboxane synthetase inhibitor and methylprednisolone effects on protamine responses in dogs. 1992 Anesth. Analg. pmid:1734796
Fink MP et al. Ibuprofen improves survival but does not ameliorate increased gut mucosal permeability in endotoxic pigs. 1992 Arch Surg pmid:1734850
Kishi Y et al. Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris. 1992 Am. Heart J. pmid:1736562
Chiabrando C et al. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects. 1992 Biochim. Biophys. Acta pmid:1737057
Sood BG et al. PGE2/TXB2 imbalance in neonatal hypoxemic respiratory failure. 2007 Acta Paediatr. pmid:17376184
Bureau MF et al. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung. 1992 J. Pharmacol. Exp. Ther. pmid:1738127
Clive DM et al. Potassium homeostasis with indomethacin therapy in normal subjects. 1992 Am. J. Kidney Dis. pmid:1739077
Kean WF et al. The pharmacokinetics of flurbiprofen in younger and elderly patients with rheumatoid arthritis. 1992 J Clin Pharmacol pmid:1740536
Zhi-Yong S et al. Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion. 1992 J Trauma pmid:1740793
Fratacci MD et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. 1991 Anesthesiology pmid:1741521
Yu XM et al. [Relations of platelet phospholipid fatty acids to thrombotic risk factors in middle-aged and geriatric patients with hyperlipidemia]. 2007 Zhonghua Yi Xue Za Zhi pmid:17418017
Chiang N and Serhan CN New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications. 2006 Compr Ther pmid:17435267
Zheng BH et al. [The effect of inhaled nitric oxide on endothelium-derived angiokinetic factors in patients with acute high altitude disease]. 2007 Zhonghua Jie He He Hu Xi Za Zhi pmid:17445476
Maree AO and Fitzgerald DJ Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. 2007 Circulation pmid:17452618
Gracia-Sancho J et al. Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers. 2007 J. Hepatol. pmid:17459512
Faraday N et al. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. 2007 Circulation pmid:17470694
Capone ML et al. Human pharmacology of naproxen sodium. 2007 J. Pharmacol. Exp. Ther. pmid:17473175
Zhao L et al. [Plasma PGI2 and TXA2 levels on a model of PDH in leptospirosis]. 1991 Hua Xi Yi Ke Da Xue Xue Bao pmid:1748406
Suzuki A et al. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. 2007 Am. J. Hypertens. pmid:17485012
Basselin M et al. Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. 2007 J. Neurochem. pmid:17488274
Ratzmann KP et al. Thromboxane production and platelet aggregation in type 2 diabetes mellitus without vascular complications. 1991 Klin. Wochenschr. pmid:1749204